Current techniques in MIGS, the theory behind the techniques,
relevant data on efficacy and safety
Recent advances in MIGS, ab interno and ab externo approaches,
data on products in development
MIGS used in clinical practice. Which product for which patient
Key factors for successful implantation of MIGS
1. WHO IS OUR TARGET AUDIENCE
This educational activity is intended for comprehensive
ophthalmologists, ophthalmology residents and fellows.
2. WHAT ARE OUR EDUCATIONAL OBJECTIVES
Medical knowledge, professionalism and patient care. Each issue
has its own educational objectives that were established to guide
the development of the content.
3. INSTRUCTIONAL FORMAT
Glaucoma Now is an eight to sixteen page newsletter-format,
enduring material published three times a year. Each issue has a
major theme. Within each issue there are four sections, each of
which treats some aspect of the theme in a predefined way.
`Special Focus` is a major review that outlines the expert
consensus on the topic area, bringing together research findings
and the judgement of highly regarded clinical scientists (length of
chapter: 4 pages, approximately 2000 words; number of
illustrations: 4-6; number of references: 15-20). `What's new`
examines research directions and the latest findings in the theme
area (length of chapter: 2 pages, approximately 1000 words; number
of illustrations: 3-4; number of references: 5-10).
`Clinical Issues` relates research to clinical practice (length of
chapter: 1 page, approximately 550 words; number of illustrations:
1-2; number of references: 3-6).
`Practical Tips` describes a related technique or procedure in
sufficient detail to allow its immediate adoption in the clinic
(length of chapter: 1 page, approximately 550 words; number of
illustrations: 1-2; number of references: 1-5).
4. NEEDS ASSESSMENT
Advances in the diagnosis and treatment of glaucoma are taking
place with enormous speed. On May 4 of 2016, a PubMed search under
the keyword glaucoma found 1236 peer-reviewed papers published on
the subject in the current year alone.
From a clinical perspective, however, glaucoma is neither
diagnosed nor treated exclusively by subspecialists. Rather,
glaucoma is widely treated by comprehensive and general
ophthalmologists, who are greatly challenged to keep up with that
volume of research.
In each of the three projected annual issues of `Glaucoma now`, a
major topic area in glaucoma damage mechanisms, pathogenesis,
diagnosis, or management will be addressed by pre-eminent global
authorities in the field. These individuals are asked to review and
summarize advances with an emphasis on incorporating them into
to help us put this current edition together within the timeframe
specified in our invitation letter we would like to ask you for the
We would like to thank you for your support!
Download literature request form here.
Download author disclosure form here.
Please make sure to also fill in the author disclosure
form and send back to the contact address listed